Difference between revisions of "Part:BBa K5133004"
Line 8: | Line 8: | ||
==<b>Brief introduction</b>== | ==<b>Brief introduction</b>== | ||
− | This | + | This composite part is derived from plasmid pJL1 (Addgene: #69496)<sup>[1]</sup>, consisting of four basic parts: T7 promoter (<bbpart>BBa_K5133000</bbpart>), ribosome binding site (RBS, <bbpart>BBa_K5133001</bbpart>), coding sequence of superfolder green fluorescent protein (sfGFP, <bbpart>BBa_K5133002</bbpart>), and T7 terminator (<bbpart>BBa_K5133003</bbpart>)<b>Figure 1, 2</b>.The plasmid pJL1 is commonly used for the <i>in vitro</i> sfGFP expression of cell-free protein synthesis (CFPS)<sup>[2]</sup>, however, an iGEM-based CFPS plasmid has not yet been constructed and characterized yet. Hence, this part is established to demonstrate the feasibility of CFPS in our project. |
− | ==< | + | <center> |
+ | <html lang="en"> | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <title>Resizable Image</title> | ||
+ | <style> | ||
+ | .resizable-img1 { | ||
+ | max-width: 60%; | ||
+ | height: auto; | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | <img src="https://static.igem.wiki/teams/5133/bba-k5133004-33.jpg" class="resizable-img1"> | ||
+ | </body> | ||
+ | </html> | ||
+ | </center> | ||
+ | |||
+ | |||
+ | <center><b>Figure 1. Schematic design of this part, generated by SnapGene.</b></center> | ||
+ | |||
− | |||
Line 30: | Line 50: | ||
</head> | </head> | ||
<body> | <body> | ||
− | <img src="https://static.igem.wiki/teams/5133/bba- | + | <img src="https://static.igem.wiki/teams/5133/bba-k5133004-333.jpg" class="resizable-img1"> |
</body> | </body> | ||
</html> | </html> | ||
Line 36: | Line 56: | ||
− | <center><b>Figure | + | <center><b>Figure 2. Detailed constitute of this composite part, including four basic parts: T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS <bbpart>BBa_K5133001</bbpart>), sfGFP <bbpart>BBa_K5133002</bbpart>), and T7 terminator (<bbpart>BBa_K5133003</bbpart>).</b></center> |
+ | |||
+ | |||
+ | ==<b>Design and characterization</b>== | ||
+ | |||
+ | The plasmid design of this biological part is shown as <b>Figure 1</b>, assembled with iGEM standard backbone <bbpart>pSB1C3</bbpart>. To validate the correctness of DNA sequence, result of Sanger sequencing for <bbpart>BBa_K5133004</bbpart> show the successful assembly among T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS (<bbpart>BBa_K5133001</bbpart>), sfGFP (this part), and T7 terminator (<bbpart>BBa_K5133003</bbpart>) in <b>Figure 2</b>. | ||
Revision as of 12:15, 29 July 2024
sfGFP generator for CFPS (cell-free protein synthesis)
Group: GEC-China (iGEM 2024, team number: #5133)
Brief introduction
This composite part is derived from plasmid pJL1 (Addgene: #69496)[1], consisting of four basic parts: T7 promoter (BBa_K5133000), ribosome binding site (RBS, BBa_K5133001), coding sequence of superfolder green fluorescent protein (sfGFP, BBa_K5133002), and T7 terminator (BBa_K5133003)Figure 1, 2.The plasmid pJL1 is commonly used for the in vitro sfGFP expression of cell-free protein synthesis (CFPS)[2], however, an iGEM-based CFPS plasmid has not yet been constructed and characterized yet. Hence, this part is established to demonstrate the feasibility of CFPS in our project.
Design and characterization
The plasmid design of this biological part is shown as Figure 1, assembled with iGEM standard backbone pSB1C3. To validate the correctness of DNA sequence, result of Sanger sequencing for BBa_K5133004 show the successful assembly among T7 promoter (BBa_K5133000), RBS (BBa_K5133001), sfGFP (this part), and T7 terminator (BBa_K5133003) in Figure 2.
Usages
This part is used for the construction of composite part BBa_K5133004 (sfGFP generator) to demonstrate the feasibility of CFPS in our project. Please see the detailed experimental results in BBa_K5133004.
DNA sequence (from 5' to 3')
atgagcaaaggtgaagaactgtttaccggcgttgtgccgattctggtggaactggatggcgatgtgaacggtcacaaattcagcgtgcgtggtgaaggtgaaggcgatgccacgattggcaaactgacgctgaaattt atctgcaccaccggcaaactgccggtgccgtggccgacgctggtgaccaccctgacctatggcgttcagtgttttagtcgctatccggatcacatgaaacgtcacgatttctttaaatctgcaatgccggaaggctat gtgcaggaacgtacgattagctttaaagatgatggcaaatataaaacgcgcgccgttgtgaaatttgaaggcgataccctggtgaaccgcattgaactgaaaggcacggattttaaagaagatggcaatatcctgggc cataaactggaatacaactttaatagccataatgtttatattacggcggataaacagaaaaatggcatcaaagcgaattttaccgttcgccataacgttgaagatggcagtgtgcagctggcagatcattatcagcag aataccccgattggtgatggtccggtgctgctgccggataatcattatctgagcacgcagaccgttctgtctaaagatccgaacgaaaaaggcacgcgggaccacatggttctgcacgaatatgtgaatgcggcaggt attacgtggagccatccgcagttcgaaaaataa
Red font: Strep-Tag II, from pJL1[1]
References
[1] https://www.addgene.org/69496/
[2] Ba, F. et al. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology. Biotechnology Journal 19, 2300327 (2024). doi: 10.1002/biot.202300327
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 51
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 51
- 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 51
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 32